Femasys is trading 5% down at $2.64 as broader risk-off sentiment pressured smaller risk assets during the September 14, 2026 session.
- No fresh company-specific announcement was identified; the latest material update was the September 9 CapexMD partnership expanding financing access for FemaSeed and related fertility products.
- Major indexes were also lower, and the decline appears primarily global rather than company-specific.